Pages

Showing posts with label immunological memory. Show all posts
Showing posts with label immunological memory. Show all posts

Monday, January 18, 2021

Study: No Need for Adult Tetanus, Diphtheria Shots [Blog post includes reference to Scholarly Article - Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules]

Title:
Study: No Need for Adult Tetanus, Diphtheria Shots
 
Author:
Robert Preidt
 
Published:
WebMD, 26 February 2020
 
From the article:
* Countering a U.S. government advisory, a new study suggests that adults may not need regular booster shots for tetanus and diphtheria if they received a complete vaccination series as children.

* The study was published Feb. 25 in the journal Clinical Infectious Diseases (Incidence of Tetanus and Diphtheria in Relation to Adult Vaccination Schedules, 25 February 2020).

Authors:
Ariel M Slifka, Byung Park, Lina Gao & Mark K Slifka

Abstract of Scholarly Article mentioned above:
Background 
The World Health Organization (WHO) does not recommend routine adult booster vaccination for tetanus and diphtheria after completion of the childhood vaccination series. However, many countries continue to implement adult booster vaccinations, leading to the question of whether this is necessary to reduce the incidence of these 2 rare diseases.  
 
Methods 
We conducted an observational cohort study based on WHO case reports from 2001 through 2016. We compared the incidence of tetanus and diphtheria in 31 North American and European countries that either do or do not recommend adult booster vaccination.  
 
Results 
Countries that vaccinate adults every 5–20 years (group 1) were compared with countries that do not routinely vaccinate adults for tetanus or diphtheria (group 2). Comparison of group 1 vs group 2 revealed no significant decline in tetanus incidence rates among countries that vaccinate adults (P = .52; risk ratio [RR] = 0.78; 95% confidence interval [CI], .36 to 1.70). The risk of contracting diphtheria was increased among countries that vaccinate adults due to inclusion of Latvia, a country that had poor vaccination coverage (P < .001). However, if Latvia is excluded, there is no difference in diphtheria incidence between countries that do or do not routinely vaccinate adults (P = .26; RR = 2.46; 95% CI, .54 to 11.23).  
 
Conclusions 
Review of >11 billion person-years of incidence data revealed no benefit associated with performing adult booster vaccinations against tetanus or diphtheria. Similar to other vaccines, this analysis supports the WHO position on adult booster vaccination and, if approved by governing health authorities, this may allow more countries to focus healthcare resources on vulnerable and undervaccinated populations.    

Friday, November 20, 2020

Immunological memory to SARS-CoV-2 assessed for greater than six months after infection [bioRxiv, 16 November 2020 - preprint]

Title:
Immunological memory to SARS-CoV-2 assessed for greater than six months after infection
 
Authors:
Jennifer M. Dan, Jose Mateus, Yu Kato, Kathryn M. Hastie, Caterina E. Faliti, Sydney I. Ramirez, April Frazier, Esther Dawen Yu, Alba Grifoni, Stephen A. Rawlings, Bjoern Peters, Florian Krammer, Viviana Simon, Erica Ollmann Saphire, Davey M. Smith, Daniela Weiskopf, Alessandro Sette & Shane Crotty

Published:
bioRxiv, 16 November 2020
[Keep in mind that this article is a preprint and not yet peer reviewed.]

Abstract:
Understanding immune memory to SARS-CoV-2 is critical for improving diagnostics and vaccines, and for assessing the likely future course of the pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 185 COVID-19 cases, including 41 cases at ≥6 months post-infection. Spike IgG was relatively stable over 6+ months. Spike-specific memory B cells were more abundant at 6 months than at 1 month. SARS-CoV-2-specific CD4+ T cells and CD8+ T cells declined with a half-life of 3-5 months. By studying antibody, memory B cell, CD4+ T cell, and CD8+ T cell memory to SARS-CoV-2 in an integrated manner, we observed that each component of SARS-CoV-2 immune memory exhibited distinct kinetics.